The global health community is locked in an urgent race against time as an Ebola epidemic continues to surge across Africa.

There is no approved vaccine to curb the Ebola outbreak in the Democratic Republic of the Congo and Uganda. But new funding ...

The Bundibugyo virus, a little known type, previously had caused just two small outbreaks. Now it’s at the center of a ...

There is an effective vaccine for Ebola — but not for the variety spreading rapidly in the Democratic Republic of Congo.

But these events also serve as a reminder that outbreaks are rarely controlled by vaccines alone. While vaccines play an ...

Explore the development of vaccines and treatments for Bundibugyo Ebola amid the ongoing outbreak in the Democratic Republic ...

Under the plans, CEPI has committed up to $50 million to US-based Moderna for preclinical development and Phase 1 clinical ...

With no licensed vaccines available to protect against the Ebola virus currently spreading in the Congo, efforts are underway ...

A vaccine won’t be coming soon to help quell the Ebola outbreak raging through the Democratic Republic of Congo. There are no existing vaccines targeted to the species of Ebola that is already ...

A dangerous new Ebola outbreak is intensifying in the northeastern region of the Democratic Republic of the Congo, fueled by ...

Supported by funding from the Coalition for Epidemic Preparedness Innovations (CEPI), the collaboration aims to rapidly ...

East Africa’s Ebola outbreak, driven by the rare Bundibugyo strain, has no approved vaccine or treatment, prompting urgent ...